Was Abano’s rights issue a ploy to flush out its dissident major shareholder?
Healthcare Partners sold its 19% Abano stake for $36.7 million.
Hot Topic
EARNINGS
If Abano Healthcare’s $35 million rights issue was a ploy to force its dissident major shareholder to sell its stake, it worked.
Late on Wednesday, Healthcare Partners sold its 19% stake in Abano for a total of $36.7 million.
It sold its 4.08 million shares at $8.85 per share, a 6.3% discount
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
NZ$399.00 / yearly
Smartphone Only Annual Subscription
NZ$299.00 / yearly
Monthly Premium Online Subscription
NZ$49.95 / monthly
Smartphone Only Subscription
NZ$29.95 / monthly
Premium Group Membership 10 Users
NZ$385+GST / monthly
$38.5 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$660+GST / monthly
$33 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1375+GST / monthly
$27.5 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$2100+GST / monthly
$21 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Jenny Ruth
Thu, 17 Aug 2017
Thu, 17 Aug 2017
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Was Abano’s rights issue a ploy to flush out its dissident major shareholder?
69340